{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:33:34Z","timestamp":1773801214417,"version":"3.50.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc. Diabetol. \u2013 Endocrinol. Rep."],"DOI":"10.1186\/s40842-026-00282-8","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T23:02:05Z","timestamp":1773788525000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fuel toxicity-associated spectrum (FTAS): a unifying nomenclature for metabolic disorders"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2345-9493","authenticated-orcid":false,"given":"Pichakacheri","family":"Sureshkumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"282_CR1","doi-asserted-by":"publisher","unstructured":"GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease Study 2021. Lancet. 2023;402(10397):203\u201334. https:\/\/doi.org\/10.1016\/S0140-6736(23)01301-6.","DOI":"10.1016\/S0140-6736(23)01301-6"},{"issue":"20","key":"282_CR2","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, et al. A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American heart Association. Circulation. 2023;148(20):1636\u201364. https:\/\/doi.org\/10.1161\/CIR.0000000000001186.","journal-title":"Circulation"},{"issue":"3","key":"282_CR3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41591-020-0756-0","volume":"26","author":"N Sattar","year":"2020","unstructured":"Sattar N, Gill JMR, Alazawi W. Improving prevention strategies for cardiometabolic disease. Nat Med. 2020;26(3):320\u201325. https:\/\/doi.org\/10.1038\/s41591-020-0756-0.","journal-title":"Nat Med"},{"issue":"2","key":"282_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","volume":"41","author":"F Cosentino","year":"2020","unstructured":"Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255\u2013323. https:\/\/doi.org\/10.1093\/eurheartj\/ehz486.","journal-title":"Eur Heart J"},{"issue":"4","key":"282_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41591-020-0803-x","volume":"26","author":"F Rubino","year":"2020","unstructured":"Rubino F, Puhl RM, Cummings DE, Eckel RH, Ryan DH, Mechanick JI, et al. Joint international consensus statement for ending stigma of obesity. Nat Med. 2020;26(4):485\u201397. https:\/\/doi.org\/10.1038\/s41591-020-0803-x.","journal-title":"Nat Med"},{"issue":"7","key":"282_CR6","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J. International consensus panel. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999\u20132014.e1. https:\/\/doi.org\/10.1053\/j.gastro.2019.11.312.","journal-title":"Gastroenterology"},{"issue":"5","key":"282_CR7","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/hep.32499","volume":"76","author":"ZM Younossi","year":"2022","unstructured":"Younossi ZM, Paik JM, Al Shabeeb R, Golabi P, Younossi I, Henry L. Are there outcome differences between NAFLD and metabolic-associated fatty liver disease? Hepatology. 2022;76(5):1423\u201337. https:\/\/doi.org\/10.1002\/hep.32499.","journal-title":"Hepatology"},{"issue":"6","key":"282_CR8","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356. https:\/\/doi.org\/10.1016\/j.jhep.2023.06.003.","journal-title":"J Hepatol"},{"issue":"1","key":"282_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","volume":"19","author":"JV Lazarus","year":"2022","unstructured":"Lazarus JV, Mark HE, Anstee QM, Arab JP, Batterham RL, Castera L, et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nat Rev Gastroenterol Hepatol. 2022;19(1):60\u201378. https:\/\/doi.org\/10.1038\/s41575-021-00523-4.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"17","key":"282_CR10","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American heart Association\/National heart. Lung, Blood Inst Sci Statement. Circ. 2005;112(17):2735\u201352. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.169404.","journal-title":"Lung, Blood Inst Sci Statement. Circ"},{"issue":"3","key":"282_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.bbalip.2009.12.007","volume":"1801","author":"RH Unger","year":"2010","unstructured":"Unger RH, Clark GO, Scherer PE, Orci L. Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim Biophys Acta. 2010;1801(3):209\u201314. https:\/\/doi.org\/10.1016\/j.bbalip.2009.12.007.","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"282_CR12","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1056\/NEJMra1011035","volume":"371","author":"GI Shulman","year":"2014","unstructured":"Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med. 2014;371(12):1131\u201341. https:\/\/doi.org\/10.1056\/NEJMra1011035.","journal-title":"N Engl J Med"},{"issue":"20","key":"282_CR13","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1016\/j.jacc.2018.03.509","volume":"71","author":"M Packer","year":"2018","unstructured":"Packer M. Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium. J Am Coll Cardiol. 2018;71(20):2360\u201372. https:\/\/doi.org\/10.1016\/j.jacc.2018.03.509.","journal-title":"J Am Coll Cardiol"},{"issue":"7785","key":"282_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","volume":"576","author":"M Roden","year":"2019","unstructured":"Roden M, Shulman GI. The integrative biology of type 2 diabetes. Nature. 2019;576(7785):51\u201360. https:\/\/doi.org\/10.1038\/s41586-019-1797-8.","journal-title":"Nature"},{"issue":"9","key":"282_CR15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","volume":"7","author":"IJ Neeland","year":"2019","unstructured":"Neeland IJ, Ross R, Despr\u00e9s JP, Matsuzawa Y, Yamashita S, Shai I, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7(9):715\u201325. https:\/\/doi.org\/10.1016\/S2213-8587(19)30084-1.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"282_CR16","doi-asserted-by":"publisher","first-page":"15015","DOI":"10.1038\/nrdp.2015.15","volume":"1","author":"P L\u00e9vy","year":"2015","unstructured":"L\u00e9vy P, Kohler M, Wt M, Barb\u00e9 F, Rd M, Somers VK, et al. Obstructive sleep apnoea syndrome. Nat Rev Dis Primers. 2015;1:15015. https:\/\/doi.org\/10.1038\/nrdp.2015.15.","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"282_CR17","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/s41584-018-0073-x","volume":"14","author":"F Berenbaum","year":"2018","unstructured":"Berenbaum F, Wallace IJ, Lieberman DE, Felson DT. Modern-day environmental factors in the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2018;14(11):674\u201381. https:\/\/doi.org\/10.1038\/s41584-018-0073-x.","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"282_CR18","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s00125-008-1116-7","volume":"51","author":"R Taylor","year":"2008","unstructured":"Taylor R. Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause. Diabetologia. 2008;51(10):1781\u201389. https:\/\/doi.org\/10.1007\/s00125-008-1116-7.","journal-title":"Diabetologia"},{"issue":"10120","key":"282_CR19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","volume":"391","author":"MEJ Lean","year":"2018","unstructured":"Lean MEJ, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018;391(10120):541\u201351. https:\/\/doi.org\/10.1016\/S0140-6736(17)33102-1.","journal-title":"Lancet"},{"issue":"7","key":"282_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1042\/CS20140553","volume":"128","author":"R Taylor","year":"2015","unstructured":"Taylor R, Holman RR. Normal weight individuals who develop type 2 diabetes: the personal fat threshold. Clin Sci (Lond). 2015;128(7):405\u201310. https:\/\/doi.org\/10.1042\/CS20140553.","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"282_CR21","doi-asserted-by":"publisher","first-page":"372","DOI":"10.4158\/EP161688.PS","volume":"23","author":"JI Mechanick","year":"2017","unstructured":"Mechanick JI, Hurley DL, Garvey WT. Adiposity-based chronic disease as a new diagnostic term: the American Association of clinical endocrinologists and American college of endocrinology position statement. Endocr Pract. 2017;23(3):372\u201378. https:\/\/doi.org\/10.4158\/EP161688.PS.","journal-title":"Endocr Pract"},{"key":"282_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/978-3-7091-0715-7_26","volume-title":"Metabolism of human diseases","author":"A Welters","year":"2014","unstructured":"Welters A, Lammert E. Diabetes Mellitus. In: Lammert E, Zeeb M, editors. Metabolism of human diseases. Springer Vienna; 2014. p. 185\u201391. https:\/\/doi.org\/10.1007\/978-3-7091-0715-7_26."},{"issue":"16","key":"282_CR23","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1042\/CS20230586","volume":"137","author":"R Taylor","year":"2023","unstructured":"Taylor R, Barnes AC, Hollingsworth KG, Irvine KM, Solovyova AS, Clark L, et al. Aetiology of type 2 diabetes in people with a \u2018normal\u2019 body mass index: testing the personal fat threshold hypothesis. Clin Sci (Lond). 2023;137(16):1333\u201346. https:\/\/doi.org\/10.1042\/CS20230586.","journal-title":"Clin Sci (Lond)"},{"issue":"12","key":"282_CR24","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s40265-021-01554-6","volume":"81","author":"S Jacob","year":"2021","unstructured":"Jacob S, Krentz AJ, Deanfield J, Ryd\u00e9n L. Evolution of type 2 diabetes management from a glucocentric approach to cardio-renal risk reduction: the new paradigm of care. Drugs. 2021;81(12):1373\u201379. https:\/\/doi.org\/10.1007\/s40265-021-01554-6.","journal-title":"Drugs"},{"issue":"4","key":"282_CR25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JFE, Nauck MA, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375(4):311\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1603827.","journal-title":"N Engl J Med"},{"issue":"2","key":"282_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/MED.0b013e3283444b09","volume":"18","author":"G Boden","year":"2011","unstructured":"Boden G. Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes. 2011;18(2):139\u201343. https:\/\/doi.org\/10.1097\/MED.0b013e3283444b09.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"2","key":"282_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri2921","volume":"11","author":"N Ouchi","year":"2011","unstructured":"Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85\u201397. https:\/\/doi.org\/10.1038\/nri2921.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"282_CR28","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1172\/JCI45887","volume":"121","author":"K Sun","year":"2011","unstructured":"Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest. 2011;121(6):2094\u2013101. https:\/\/doi.org\/10.1172\/JCI45887.","journal-title":"J Clin Invest"},{"issue":"3","key":"282_CR29","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/1468-0009.12416","volume":"97","author":"EH Wagner","year":"2019","unstructured":"Wagner EH. Organizing care for patients with chronic illness revisited. Milbank Q. 2019;97(3):659\u201364. https:\/\/doi.org\/10.1111\/1468-0009.12416.","journal-title":"Milbank Q"},{"issue":"1","key":"282_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.molmed.2011.07.010","volume":"18","author":"M Cnop","year":"2012","unstructured":"Cnop M, Foufelle F, Velloso LA. Endoplasmic reticulum stress, obesity and diabetes. Trends Mol Med. 2012;18(1):59\u201368. https:\/\/doi.org\/10.1016\/j.molmed.2011.07.010.","journal-title":"Trends Mol Med"},{"issue":"2","key":"282_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s001250051591","volume":"44","author":"R Singh","year":"2001","unstructured":"Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia. 2001;44(2):129\u201346. https:\/\/doi.org\/10.1007\/s001250051591.","journal-title":"Diabetologia"},{"issue":"5","key":"282_CR32","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.jmb.2019.09.016","volume":"432","author":"M Lytrivi","year":"2020","unstructured":"Lytrivi M, Castell AL, Poitout V, Cnop M. Recent insights into mechanisms of \u03b2-cell lipo- and glucolipotoxicity in type 2 diabetes. J Mol Biol. 2020;432(5):1514\u201334. https:\/\/doi.org\/10.1016\/j.jmb.2019.09.016.","journal-title":"J Mol Biol"},{"issue":"1","key":"282_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1172\/JCI77812","volume":"126","author":"VT Samuel","year":"2016","unstructured":"Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest. 2016;126(1):12\u201322. https:\/\/doi.org\/10.1172\/JCI77812.","journal-title":"J Clin Invest"},{"issue":"1","key":"282_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41380-018-0017-5","volume":"24","author":"Y Milaneschi","year":"2019","unstructured":"Milaneschi Y, Simmons WK, van Rossum Efc, Penninx BW. Depression and obesity: evidence of shared biological mechanisms. Mol Psychiatry. 2019;24(1):18\u201333. https:\/\/doi.org\/10.1038\/s41380-018-0017-5.","journal-title":"Mol Psychiatry"},{"issue":"8","key":"282_CR35","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","volume":"375","author":"B Lauby-Secretan","year":"2016","unstructured":"Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K, et al. Body fatness and cancer\u2013viewpoint of the IARC working group. N Engl J Med. 2016;375(8):794\u201398. https:\/\/doi.org\/10.1056\/NEJMsr1606602.","journal-title":"N Engl J Med"},{"issue":"35","key":"282_CR36","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1200\/JCO.2016.67.9712","volume":"34","author":"BD Hopkins","year":"2016","unstructured":"Hopkins BD, Goncalves MD, Cantley LC. Obesity and cancer mechanisms: cancer metabolism. J Clin Oncol. 2016;34(35):4277\u201383. https:\/\/doi.org\/10.1200\/JCO.2016.67.9712. Epub 2016 Nov 7.","journal-title":"J Clin Oncol"},{"issue":"2","key":"282_CR37","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1152\/physrev.00024.2006","volume":"87","author":"DB Savage","year":"2007","unstructured":"Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev. 2007;87(2):507\u201320. https:\/\/doi.org\/10.1152\/physrev.00024.2006.","journal-title":"Physiol Rev"},{"issue":"12","key":"282_CR38","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/cells10123328","volume":"10","author":"EA Vilas-Boas","year":"2021","unstructured":"Vilas-Boas EA, Almeida DC, Roma LP, Ortis F, Carpinelli AR. Lipotoxicity and \u03b2-cell failure in type 2 diabetes: oxidative stress linked to NADPH oxidase and ER stress. Cells. 2021;10(12):3328. https:\/\/doi.org\/10.3390\/cells10123328.","journal-title":"Cells"},{"issue":"5","key":"282_CR39","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.tem.2014.03.002","volume":"25","author":"P Arner","year":"2014","unstructured":"Arner P, Langin D. Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance. Trends Endocrinol Metab. 2014;25(5):255\u201362. https:\/\/doi.org\/10.1016\/j.tem.2014.03.002.","journal-title":"Trends Endocrinol Metab"},{"key":"282_CR40","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee; 2. Diagnosis and classification of diabetes: standards of care in diabetes\u20142025. Diabetes Care. 2025;48(Suppl_1):S27\u201349. https:\/\/doi.org\/10.2337\/dc25-S002.","DOI":"10.2337\/dc25-S002"},{"issue":"5","key":"282_CR41","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1172\/JCI25102","volume":"115","author":"KE Wellen","year":"2005","unstructured":"Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115(5):1111\u201319. https:\/\/doi.org\/10.1172\/JCI25102.","journal-title":"J Clin Invest"},{"key":"282_CR42","doi-asserted-by":"publisher","unstructured":"Britton KA, Fox CS. Ectopic fat depots and cardiovascular disease. Circulation. 2011;124(24):e837\u201341. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.077602.","DOI":"10.1161\/CIRCULATIONAHA.111.077602"},{"issue":"6","key":"282_CR43","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1172\/JCI57132","volume":"121","author":"CN Lumeng","year":"2011","unstructured":"Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest. 2011;121(6):2111\u201317. https:\/\/doi.org\/10.1172\/JCI57132.","journal-title":"J Clin Invest"},{"issue":"3","key":"282_CR44","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1172\/JCI134165","volume":"130","author":"GI Smith","year":"2020","unstructured":"Smith GI, Shankaran M, Yoshino M, Schweitzer GG, Chondronikola M, Beals JW, et al. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease. J Clin Invest. 2020;130(3):1453\u201360. https:\/\/doi.org\/10.1172\/JCI134165.","journal-title":"J Clin Invest"},{"issue":"6","key":"282_CR45","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","volume":"54","author":"M Brownlee","year":"2005","unstructured":"Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615\u201325. https:\/\/doi.org\/10.2337\/diabetes.54.6.1615.","journal-title":"Diabetes"},{"issue":"5","key":"282_CR46","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52(5):1836\u201346. https:\/\/doi.org\/10.1002\/hep.24001.","journal-title":"Hepatology"},{"issue":"6","key":"282_CR47","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.cell.2014.11.034","volume":"159","author":"DM Muoio","year":"2014","unstructured":"Muoio DM. Metabolic inflexibility: when mitochondrial indecision leads to metabolic gridlock. Cell. 2014;159(6):1253\u201362. https:\/\/doi.org\/10.1016\/j.cell.2014.11.034.","journal-title":"Cell"},{"issue":"11","key":"282_CR48","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.2337\/diabetes.50.11.2579","volume":"50","author":"OP Bachmann","year":"2001","unstructured":"Bachmann OP, Dahl DB, Brechtel K, Machann J, Haap M, Maier T, et al. Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes. 2001;50(11):2579\u201384. https:\/\/doi.org\/10.2337\/diabetes.50.11.2579.","journal-title":"Diabetes"},{"issue":"22","key":"282_CR49","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117\u201328. https:\/\/doi.org\/10.1056\/NEJMoa1504720.","journal-title":"N Engl J Med"},{"issue":"10019","key":"282_CR50","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","volume":"387","author":"MJ Armstrong","year":"2016","unstructured":"Armstrong MJ, Gaunt P, Aithal GP, Barton D, Hull D, Parker R, et al. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. Lancet. 2016;387(10019):679\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(15)00803-X.","journal-title":"Lancet"},{"issue":"11","key":"282_CR51","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.2337\/dci22-0034","volume":"45","author":"MJ Davies","year":"2022","unstructured":"Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, et al. Management of Hyperglycemia in type 2 diabetes, 2022. A consensus report by the American diabetes Association (ADA) and the European Association for the Study of diabetes (EASD). Diabetes Care. 2022;45(11):2753\u201386. https:\/\/doi.org\/10.2337\/dci22-0034.","journal-title":"Diabetes Care"},{"issue":"1","key":"282_CR52","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3390\/jcm13010278","volume":"13","author":"P Danpanichkul","year":"2024","unstructured":"Danpanichkul P, Suparan K, Kim D, Wijarnpreecha K. What is new in metabolic dysfunction-associated steatotic liver disease in lean individuals: from bench to bedside. J Clin Med. 2024;13(1):278. https:\/\/doi.org\/10.3390\/jcm13010278.","journal-title":"J Clin Med"},{"issue":"4","key":"282_CR53","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2337\/dc12-1805","volume":"36","author":"R Taylor","year":"2013","unstructured":"Taylor R. Type 2 diabetes: etiology and reversibility. Diabetes Care. 2013;36(4):1047\u201355. https:\/\/doi.org\/10.2337\/dc12-1805.","journal-title":"Diabetes Care"},{"issue":"7","key":"282_CR54","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1007\/s00125-010-1684-1","volume":"53","author":"RA DeFronzo","year":"2010","unstructured":"DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The claude bernard lecture 2009. Diabetologia. 2010;53(7):1270\u201387. https:\/\/doi.org\/10.1007\/s00125-010-1684-1.","journal-title":"Diabetologia"},{"issue":"4","key":"282_CR55","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrendo.2010.217","volume":"7","author":"MO Goodarzi","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7(4):219\u201331. https:\/\/doi.org\/10.1038\/nrendo.2010.217.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"282_CR56","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S2213-8587(14)70065-8","volume":"2","author":"de Vries Apj","year":"2014","unstructured":"de Vries Apj, Ruggenenti P, Ruan XZ, Praga M, Cruzado JM, Bajema IM, et al. Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease. Lancet Diabetes Endocrinol. 2014;2(5):417\u201326. https:\/\/doi.org\/10.1016\/S2213-8587(14)70065-8.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"282_CR57","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cmet.2012.11.012","volume":"17","author":"C Rask-Madsen","year":"2013","unstructured":"Rask-Madsen C, King GL. Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab. 2013;17(1):20\u201333. https:\/\/doi.org\/10.1016\/j.cmet.2012.11.012.","journal-title":"Cell Metab"},{"issue":"5","key":"282_CR58","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cmet.2011.07.015","volume":"14","author":"KE Bornfeldt","year":"2011","unstructured":"Bornfeldt KE, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 2011;14(5):575\u201385. https:\/\/doi.org\/10.1016\/j.cmet.2011.07.015.","journal-title":"Cell Metab"},{"key":"282_CR59","doi-asserted-by":"publisher","unstructured":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81(3):492\u2013542. https:\/\/doi.org\/10.1016\/j.jhep.2024.04.031.","DOI":"10.1016\/j.jhep.2024.04.031"},{"key":"282_CR60","doi-asserted-by":"publisher","unstructured":"KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1\u2013150. https:\/\/doi.org\/10.1038\/kisup.2012.73.","DOI":"10.1038\/kisup.2012.73"},{"key":"282_CR61","doi-asserted-by":"publisher","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American college of Cardiology\/American heart Association joint Committee on clinical practice guidelines. Circulation. 2022 May 3;145(18):e895\u20131032. https:\/\/doi.org\/10.1161\/CIR.0000000000001063.","DOI":"10.1161\/CIR.0000000000001063"},{"issue":"4","key":"282_CR62","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.tcm.2015.10.004","volume":"26","author":"SM Grundy","year":"2016","unstructured":"Grundy SM. Metabolic syndrome update. Trends Cardiovasc Med. 2016;26(4):364\u201373. https:\/\/doi.org\/10.1016\/j.tcm.2015.10.004.","journal-title":"Trends Cardiovasc Med"},{"issue":"9833","key":"282_CR63","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","volume":"379","author":"AG Tab\u00e1k","year":"2012","unstructured":"Tab\u00e1k AG, Herder C, Rathmann W, Brunner EJ, Kivim\u00e4ki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379(9833):2279\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(12)60283-9.","journal-title":"Lancet"},{"issue":"2","key":"282_CR64","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1055\/s-0033-1334866","volume":"39","author":"G Targher","year":"2013","unstructured":"Targher G, Byrne CD. Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic\/thrombotic and vascular complications. Semin Thromb Hemost. 2013;39(2):214\u201328. https:\/\/doi.org\/10.1055\/s-0033-1334866.","journal-title":"Semin Thromb Hemost"},{"key":"282_CR65","doi-asserted-by":"publisher","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2022;102(5S):S1\u2013127. https:\/\/doi.org\/10.1016\/j.kint.2022.06.008.","DOI":"10.1016\/j.kint.2022.06.008"},{"key":"282_CR66","doi-asserted-by":"publisher","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406\u201360. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.024.","DOI":"10.1016\/j.jhep.2018.03.024"},{"key":"282_CR67","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes\u20142024. Diabetes Care. 2024;47(Suppl 1):S158\u201378. https:\/\/doi.org\/10.2337\/dc24-S009.","DOI":"10.2337\/dc24-S009"},{"key":"282_CR68","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41746-020-0221-y","volume":"3","author":"RT Sutton","year":"2020","unstructured":"Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digit Med. 2020;3:17. https:\/\/doi.org\/10.1038\/s41746-020-0221-y.","journal-title":"NPJ Digit Med"},{"key":"282_CR69","unstructured":"World Health Organization. International classification of diseases, 11th revision (ICD-11). Geneva: World Health Organization; 2019\/2021."},{"issue":"3","key":"282_CR70","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/hep.31420","volume":"73","author":"ZM Younossi","year":"2021","unstructured":"Younossi ZM, Rinella ME, Sanyal AJ, Harrison SA, Brunt EM, Goodman Z, et al. From NAFLD to MAFLD: implications of a premature change in terminology. Hepatology. 2021;73(3):1194\u201398. https:\/\/doi.org\/10.1002\/hep.31420.","journal-title":"Hepatology"},{"issue":"10","key":"282_CR71","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184(10):2537\u201364. https:\/\/doi.org\/10.1016\/j.cell.2021.04.015.","journal-title":"Cell"},{"issue":"7640","key":"282_CR72","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature21363","volume":"542","author":"GS Hotamisligil","year":"2017","unstructured":"Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177\u201385. https:\/\/doi.org\/10.1038\/nature21363.","journal-title":"Nature"},{"key":"282_CR73","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s13410-022-01156-2","volume":"43","author":"P Sureshkumar","year":"2023","unstructured":"Sureshkumar P, Radha V, Mohan V, Kumar SS, Babu AS. Maternally inherited diabetes and deafness (MIDD)\u2014a series of case reports. Int J Diabetes Dev Ctries. 2023;43:583\u201386. https:\/\/doi.org\/10.1007\/s13410-022-01156-2.","journal-title":"Int J Diabetes Dev Ctries"},{"key":"282_CR74","doi-asserted-by":"publisher","unstructured":"Sureshkumar P, Radha V, Unnikrishnan R, Mohan V. Clinical profile of monogenic diabetes: a case series from a single South Indian diabetes clinic. Int J Diabetes Dev Ctries. 2024. https:\/\/doi.org\/10.1007\/s13410-024-01403-8.","DOI":"10.1007\/s13410-024-01403-8"},{"key":"282_CR75","doi-asserted-by":"publisher","unstructured":"Sureshkumar P, Kumar SS, Cheriyan J, Masood A. Friedreich ataxia and related diabetes: therapeutic approach targeting mitochondrial dysfunction. JCEM Case Rep. 2025;3(11):luaf215. https:\/\/doi.org\/10.1210\/jcemcr\/luaf215.","DOI":"10.1210\/jcemcr\/luaf215"},{"issue":"7","key":"282_CR76","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1161\/CIRCULATIONAHA.113.002271","volume":"128","author":"E Yu","year":"2013","unstructured":"Yu E, Calvert PA, Mercer JR, Harrison J, Baker L, Figg NL, et al. Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans. Circulation. 2013;128(7):702\u201312. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.002271.","journal-title":"Circulation"}],"container-title":["Cardiovascular Diabetology \u2013 Endocrinology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-026-00282-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40842-026-00282-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-026-00282-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T23:02:07Z","timestamp":1773788527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40842-026-00282-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["282"],"URL":"https:\/\/doi.org\/10.1186\/s40842-026-00282-8","relation":{},"ISSN":["3059-4057"],"issn-type":[{"value":"3059-4057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}